Ken Shadlen: Developing Countries in the Globalization of Pharmaceutical Patenting
Stanford Libraries is pleased to present the seventh Dr. Sam-Chung Hsieh Memorial LectureKen Shadlen: Developing Countries in the Globalization of Pharmaceutical Patenting
Historically most developing countries did not allow patents on pharmaceutical products. Fearing that the costs of having private rights of exclusion over these sorts of inventions would outweigh the benefits, most countries prohibited pharmaceutical patenting. In the closing decades of the 20th Century, however, the global politics of intellectual property underwent a fundamental shift, as new international trade rules made it obligatory for all countries to begin granting pharmaceutical patents. The globalization of pharmaceutical patenting has generated both hope, that increasing the geographic scope of patent protection would yield expanded biomedical innovation, and fear, that increasing the geographic scope of patent protection would put public health budgets under stress and leave many without access to essential medicines. Shadlen analyzes the globalization of pharmaceutical patenting, examining the rise of pharmaceutical patenting, the diversity of national responses to the new global shift, and emerging issues on the horizon.